Genotypes of carbapenem-resistant
Carbapenems are a mainstay treatment for infections caused by multidrug-resistant Acinetobacter baumannii (2, 12, 13) . Of concern, a dramatic increase of A. baumannii strains with decreased susceptibility to carbapenems has been observed in recent years both nationally (16) . This phenotypic observation is likely associated with changes in porin proteins, development of efflux pumps, modification of penicillin-binding proteins, and production of ␤-lactamase (15) . Among the four Ambler classes of ␤-lactamases, class B enzymes (metallo-␤-lactamases [MBLs] ) and several class D enzymes (carbapenem-hydrolyzing oxacillinases [CHDLs] ) hydrolyze carbapenems and produce resistance in the organism (3) . Three groups of MBLs, IMP, VIM, and SIM, have been identified in A. baumannii (19) . IMP and VIM ␤-lactamases show much stronger hydrolytic activity against carbapenems than do CHDLs while SIM confers only a moderate level of carbapenem resistance. Clinical A. baumannii strains with MBLs have been identified in Europe, Asia, and South America but not in the United States (15) . Three groups of CHDLs have been reported in A. baumannii. The OXA-23-like group is comprised of OXA-23, OXA-27, and OXA-49. OXA-24, OXA-25, OXA-26, and OXA-40 constitute the second group, which shares 60% homology with the OXA-23-like group (15) . OXA-58, sharing less than 50% identity with the other two groups, is the only member that has been identified in the third group. Contrasting the genetic heterogeneity among different groups of the OXA carbapenemases, members in the same group share more than 95% homology (3) . All the variants of CHDLs were initially identified in carbapenemresistant clinical A. baumannii isolates. The direct involvement of oxacillinases in the carbapenem resistance of A. baumannii was further demonstrated in the experimental systems. Introduction of the naturally occurring plasmids carrying the bla OXA-23 and bla OXA-58 genes into a carbapenem-susceptible A. baumannii reference strain resulted in imipenem MICs being increased between three-and fivefold (9) . Additionally, a carbapenem-resistant A. baumannii strain carrying OXA-40 became susceptible to both imipenem and meropenem when the bla OXA-40 gene was disrupted (9) .
Outbreaks associated with carbapenem-resistant A. baumannii have been reported worldwide (8) . From April 2005 to December 2005, 15 patients in our hospital were infected with a single carbapenem-resistant A. baumannii strain. Genotype analysis of the carbapenem-resistant A. baumannii strains collected before and after the outbreak revealed a major change in the genetic diversity of this resistant organism.
Strain collection, strain identification, and susceptibility testing. One hundred sixteen clinical strains (from 116 patients) of A. baumannii with an imipenem or meropenem MIC of Ն16 g/ml collected by the clinical microbiology laboratory of Northwestern Memorial Hospital in Chicago, IL, between January 2004 and July 2007 were selected for the study. The strains were recovered from blood, urine, respiratory specimens, and various body fluids. Fifteen of the strains were recovered from outpatients, and the rest of the strains were from inpatients. Fifty-nine (51%) isolates were recovered from patients hospitalized in intensive care units. Species identification was performed with the Vitek 2 system (bioMerieux, France). Manual biochemical reactions were used when identification by the Vitek 2 system failed. Antimicrobial susceptibility was initially determined by the Vitek 2 system using the AST-GN09 card according to the manufacturer's instructions, and isolates were qualitatively reported as susceptible, intermediate, or resistant according to Clinical and Laboratory Standards Institute (CLSI) guidelines (5). Susceptibility results for imipenem and meropenem were confirmed with agar dilution in accordance with CLSI standards using imipenem and meropenem obtained from United States Pharmacopoeia (Rockville, MD) (4).
Molecular typing by PFGE. Preparation of bacterial gel plugs and cell lysis were performed as previously described (18) . Whole-cell DNA was digested in a 1% agarose gel with ApaI enzyme (New England Biolabs, Beverly, MA) at 25°C for 4 h. Electrophoresis was performed with a CHEF-DRII system (Bio-Rad Laboratories, Hercules, CA) over 18.5 h at 14°C with 5 to 13 s of linear ramping at 200 V. Pulsed-field gel electrophoresis (PFGE) patterns were interpreted visually by using the criteria proposed by Tenover et al. (17) . Each PFGE type included strains with zero to six bands different.
Detection of bla OXA-23 , bla OXA-40 , bla OXA-58 , bla IMP , bla VIM , and bla SIM genes. Amplification of the genes encoding OXA-23-like, OXA-24-like, and OXA-58-like class D ␤-lactamases was carried out with PCR using primers OXA23-F (5Ј-GATC GGATTGGAGAACCAGA-3Ј), OXA23-R (5Ј-ATTCTGAC CGCATTTCCAT-3Ј), OXA24-F (5Ј-GGTTAGTTGGCCCC CTTAAA-3Ј), OXA24-R (5Ј-AGTTGAGCGAAAAGGGGA TT-3Ј), OXA58-F (5Ј-AAGTATTGGGGCTTGTGCTG-3Ј), and OXA58-R (5Ј-CCCCTCTGCGCTCTACATAC-3Ј) as previously described (20) . The sizes of the corresponding PCR products were 501 bp, 246 bp, and 599 bp. Primers OXA23-IIF (5Ј-GATGTGTCATAGTATTCGTCG-3Ј), OXA23-IIR (5Ј-T CACAACAACTAAAAGCACTG-3Ј), OXA24-IIF (5Ј-GTAC TAATCAAAGTTGTGAA-3Ј), and OXA24-IIR (5Ј-TTCCC CTAACATGAATTTGT-3Ј) were used to amplify the fulllength gene for sequencing following the previously described conditions (1) . An attempt to detect MBLs was performed by PCR amplification using primers IMP1-F (5Ј-CATGGTTTG GTGGTTCTTGT-3Ј), IMP1-R (5Ј-ATAATTTGGCGGACT TTGGC-3Ј), VIM2-F (5Ј-ATGTTCAAACTTTTGAGTAAG-3Ј), VIM2-R (5Ј-CTACTCAACGACTGAGCG-3Ј), SIM1-F (5Ј-TACAAGGGATTCGGCATCG-3Ј), and SIM1-R (5Ј-TA ATGGCCTGTTCCCATGTG-3Ј) following previously described conditions (14) .
Findings. A total of 24 distinct genotypic patterns were identified (Fig. 1) (Table 1 ). This change corresponded to the spread of PFGE type A strains. Of the 82 strains displaying resistance to both meropenem and imipenem, 94% were PFGE type A ( Table 2) .
The presence of MBL and CHDL genes in the carbapenemresistant A. baumannii strains was examined by PCR with primers for bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like oxacillinases and IMP-type, VIM-type, and SIM-type MBLs. MBLs and CHDLs including bla OXA-23-like , bla OXA-24-like , and bla OXA-58-like were absent in all A. baumannii strains of different PFGE genotypes that were resistant to meropenem but susceptible to imipenem (Table 2) . A bla OXA-23-like gene was detected in the imipenem-resistant strains with PFGE types K and X, and the bla OXA-24-like gene was detected in the imipenem-resistant strains with PFGE types A, U, and W. Se- Analysis of the molecular epidemiology of carbapenem-resistant A. baumanni in the various parts of the world indicated a considerable degree of geographic specificity in the spread of various CHDLs (15) . The bla OXA-40 gene has been identified in the outbreak strains recovered in several regions of Europe (6, 7, 11) from 1999 to 2004 and lately in the United States (10) . The dramatic increase in carbapenem-resistant A. baumannii strains in our hospital likely resulted from a local epidemic. Our study showed the bla OXA-40 gene present in the dominant clonal pattern of meropenem-and imipenem-resistant A. baumannii strains as well as in two other sporadic genetically unrelated strains. Characterization of the sequences surrounding the bla OXA-40 gene in a previous study suggested that the gene was localized on the chromosome and was not associated with any transferable elements (15) . However in a recent study, Lolans et al. demonstrated that a bla OXA-40 -specific probe was able to hybridize to the plasmid extracted from a carbapenemresistant A. baumannii strain, raising the possibility that the bla OXA-40 gene may localize on a plasmid (10) . Further study is required to determine if dissemination of the bla OXA-40 gene is the result of the strains coming from the same lineage or the result of strains exchanging a transposable genetic element.
The clinical emergence of imipenem resistance in the presence of CHDL bla OXA-23 and bla OXA-40 genes provided further evidence for the direct contribution of OXA-23 and OXA-40 to the development of imipenem resistance in A. baumannii clinical isolates. The absence of MBLs and CHDLs in the meropenem-resistant and imipenem-susceptible strains suggested that meropenem resistance was mediated by a different mechanism in the analyzed isolates. In addition to ␤-lactamases, lost or modulated outer membrane porin proteins and modifying penicillin-binding proteins were reported to be involved in the development of carbapenem resistance (15) . It is possible that these mechanisms could have conferred differential resistance to meropenem and imipenem. 
